At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
NLR VanEck Uranium+Nuclear Energy ETF
Trading 06-24 09:43:00 EDT
82.01
+0.29
+0.35%
High82.01
Low82.01
Vol14.65K
Open82.01
D1 Closing81.72
Amplitude0.00%
Mkt Cap210.48M
Tradable Cap210.48M
Total Shares2.57M
T/O1.20M
T/O Rate0.57%
Tradable Shares2.57M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
NuScale Power surges after DoE offers $900M to develop small modular reactors
Indaptus Therapeutics to Present New Cohort Data Confirming Original “Pulse-Prime” Hypothesis Via Phase 1 Clinical Trial of Decoy20 at the American Society of Clinical Oncology Annual Meeting
Indaptus Therapeutics Announces Completion of First Patient to Receive Multiple Doses of Decoy20, the Company’s Broad-Based, “Pulse-Prime” Immuno-Oncology Therapy for Advanced Solid Tumors
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes equity securities and depositary receipts issued by companies involved in uranium and nuclear energy. The fund is non-diversified.